Humacyte, Inc. (HUMA) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 18 Form 4 transactions for Humacyte, Inc. (HUMA) over the past 18 months (most recent 2026-05-20). Recent activity: Constantino Michael T. (Director) Buy 11,000 shares, Sander Dale A. (CFO and Chief Corp. Dev. Off) Sell 45,887 shares, Parikh Shamik J (Chief Medical Officer) Sell 45,887 shares, Sebelius Kathleen (Director) Buy 56,818 shares, Parikh Shamik J (Chief Medical Officer) Buy 311,100 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-05-20Constantino Michael T.DirectorBuy11,000$9,840
2026-05-20Sander Dale A.CFO and Chief Corp. Dev. OffSell45,887$41,147
2026-05-20Parikh Shamik JChief Medical OfficerSell45,887$41,147
2026-05-20Sebelius KathleenDirectorBuy56,818$50,000
2025-11-17Parikh Shamik JChief Medical OfficerBuy311,100$0
2025-11-17Sander Dale A.CFO and Chief Corp. Deve. Off.Buy311,100$0
2025-08-20Niklason Laura EPresident, CEO and DirectorSell549,360$1.0M
2025-08-20Dougan Brady WDirectorSell549,360$1.0M
2025-08-20Dougan Brady WDirectorSell1.1M$1.8M
2025-08-20Dougan Brady WDirectorSell591,685$934,862
2025-08-20Niklason Laura EPresident, CEO and DirectorSell1.1M$1.8M
2025-08-20Niklason Laura EPresident, CEO and DirectorSell591,685$934,862
2025-04-15Scheessele William JohnChief Commercial OfficerBuy6,493$9,999
2025-04-14Sander Dale A.CFO and Chief Corp. Deve. Off.Buy20,000$30,600
2025-04-14Parikh Shamik JChief Medical OfficerBuy7,500$11,625
2025-04-08Green Charles BruceDirectorBuy6,000$7,740
2025-04-08Constantino Michael T.DirectorBuy16,000$20,160
2025-04-08Sebelius KathleenDirectorBuy50,000$66,000

Source: SEC Form 4 filings · as of 2026-05-20